Scientists have developed a new antibiotic, zosurabalpin, to attack a notoriously drug-resistant family of bacteria known as carbapenem-resistant Acinetobacter baumannii, or CRAB for short, which kills many of those it infects.
Read the full post on Becker's Hospital Review - Healthcare News
